Withdrawal of Azathioprine in Inflammatory Bowel Disease Patients Who Sustain Remission: New Risk Factors for Relapse

ConclusionsAlmost half of the patients in whom AZA was withdrawn were in remission at 5  years. The candidates for withdrawal could be better identified based on corticosteroid dependence, previous surgery, timing of initiation, and indication for AZA.
Source: Digestive Diseases and Sciences - Category: Gastroenterology Source Type: research